Hyperfine, NVIDIA Team Up to Enhance AI-Driven Portable Imaging Technology

Health technology company Hyperfine is joining forces with Silicon Valley giant NVIDIA in a strategic collaboration aimed at enhancing its portable imaging technology. The partnership will leverage NVIDIA's artificial intelligence expertise and rapid computing capabilities to strengthen Hyperfine's innovative Swoop system, a portable magnetic resonance (MR) technology designed for point-of-care use.

The Swoop system represents a significant advancement in medical imaging, producing images that display the internal structure of the head in settings where conventional MRI systems are impractical or unavailable. This technology addresses critical healthcare gaps in locations where traditional imaging solutions cannot be deployed due to size, cost, or infrastructure limitations.

The collaboration between Hyperfine and NVIDIA will concentrate on two primary areas: advancing AI-powered image reconstruction and implementing real-time clinical decision support directly into the portable MRI workflow. By utilizing NVIDIA's sophisticated training and inference tools, such as NVIDIA DALI and MONAI (Medical Open Network for AI), the partnership aims to substantially improve the Swoop system's capabilities.

These enhancements are expected to improve image quality, reduce scan times, and enable quicker and more reliable diagnoses in diverse clinical settings. The integration of NVIDIA's computing power may prove particularly valuable in resource-constrained environments where rapid diagnostic capabilities are essential.

"Our mission is to make portable brain imaging faster, more intelligent, and increasingly accessible, ultimately improving health outcomes and reducing costs globally," Maria Sainz, president and CEO of Hyperfine, said in a statement. "Partnering with NVIDIA presents an incredible opportunity to advance and accelerate our AI technology. I'm thrilled about the possibilities this collaboration brings for the future."

This partnership joins NVIDIA's growing portfolio of healthcare collaborations. In February, NVIDIA announced a partnership with the Arc Institute and Stanford University to launch Evo 2, a new foundation model that understands genetic code across all domains of life. Described as the largest publicly available AI model for genomic data, Evo 2 was built using the NVIDIA DGX Cloud platform on Amazon Web Services.

Earlier in 2024, Johnson & Johnson MedTech partnered with NVIDIA to advance AI integration in surgical procedures. This alliance aims to enhance real-time analysis and expand the use of AI algorithms in surgical decision-making, education and collaboration within operating rooms. Under a memorandum of understanding, both companies agreed to accelerate the incorporation of AI into Johnson & Johnson MedTech's surgical technologies using NVIDIA's AI platform for healthcare.

In 2022, Indian health technology startup Qure.ai adopted NVIDIA's open-source framework for deploying AI medical imaging applications. The MONAI Application Packages simplify the process of integrating AI models into existing healthcare ecosystems, with Qure.ai now packaging its AI solutions for deployment using these tools to accelerate clinical impact.

Click here for the original news story.